Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Tue Apr 01 21:59:45 GMT 2025
by
admin
on
Tue Apr 01 21:59:45 GMT 2025
|
| Protein Type | RECEPTOR |
| Protein Sub Type | |
| Sequence Origin | HUMAN |
| Sequence Type | COMPLETE |
| Record UNII |
BK69YI6V0R
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
P00533
Created by
admin on Tue Apr 01 21:59:45 GMT 2025 , Edited by admin on Tue Apr 01 21:59:45 GMT 2025
|
PRIMARY | |||
|
BK69YI6V0R
Created by
admin on Tue Apr 01 21:59:45 GMT 2025 , Edited by admin on Tue Apr 01 21:59:45 GMT 2025
|
PRIMARY |
| Glycosylation Type | HUMAN |
| Glycosylation Link Type | Site |
|---|---|
| N | 1_60 |
| N | 1_69 |
| N | 1_121 |
| N | 1_152 |
| N | 1_236 |
| N | 1_276 |
| N | 1_311 |
| N | 1_331 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ANTIGEN->TARGET |
Vaccination with rindopepimut may elicit a cytotoxic T-lymphocyte (CTL) immune response against tumor cells expressing EGFRvIII.
|
||
|
|
ANTIGEN->TARGET | |||
|
LIGAND->TARGET |
|
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| MOL_WEIGHT | CHEMICAL |
|